Related references
Note: Only part of the references are listed.Advances in the Diagnosis and Management of Well-Differentiated Neuroendocrine Neoplasms
Johannes Hofland et al.
ENDOCRINE REVIEWS (2020)
Unveiling the Fragmentation Mechanisms of Modified Amino Acids as the Key for Their Targeted Identification
Maricruz Mamani-Huanca et al.
ANALYTICAL CHEMISTRY (2020)
Oxidized lipids in the metabolic profiling of neuroendocrine tumors - Analytical challenges and biological implications
Angeles Lopez-Lopez et al.
JOURNAL OF CHROMATOGRAPHY A (2020)
Cholesterol metabolism in cancer: mechanisms and therapeutic opportunities
Binlu Huang et al.
NATURE METABOLISM (2020)
MYC-Driven Small-Cell Lung Cancer is Metabolically Distinct and Vulnerable to Arginine Depletion
Milind D. Chalishazar et al.
CLINICAL CANCER RESEARCH (2019)
Oxidized glycerophosphatidylcholines in diabetes through non-targeted metabolomics: Their annotation and biological meaning
Joanna Godzien et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2019)
Multi-Omics Analyses Detail Metabolic Reprogramming in Lipids, Carnitines, and Use of Glycolytic Intermediates between Prostate Small Cell Neuroendocrine Carcinoma and Prostate Adenocarcinoma
Bei Gao et al.
METABOLITES (2019)
Specific and Non-Specific Biomarkers in Neuroendocrine Gastroenteropancreatic Tumors
Andrea Sansone et al.
CANCERS (2019)
Targeting Lysophosphatidic Acid in Cancer: The Issues in Moving from Bench to Bedside
Yan Xu
CANCERS (2019)
SEOM clinical guidelines for the diagnosis and treatment of gastroenteropancreatic and bronchial neuroendocrine neoplasms (NENs) (2018)
E. Gonzalez-Flores et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2019)
Metabolomics of Small Intestine Neuroendocrine Tumors and Related Hepatic Metastases
Alessio Imperiale et al.
METABOLITES (2019)
Untargeted LC-HRMS-based metabolomics to identify novel biomarkers of metastatic colorectal cancer
Ariadna Martin-Blazquez et al.
SCIENTIFIC REPORTS (2019)
The emerging role and targetability of the TCA cycle in cancer metabolism
Nicole M. Anderson et al.
PROTEIN & CELL (2018)
The Role of mTOR in Neuroendocrine Tumors: Future Cornerstone of a Winning Strategy?
Giuseppe Lamberti et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Knowledge-based metabolite annotation tool: CEU Mass Mediator
Alberto Gil de la Fuente et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2018)
Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real-World Data from the Spanish Tumor Registry (R-GETNE)
Barbara Nunez-Valdovinos et al.
ONCOLOGIST (2018)
Eicosanoids in prostate cancer
Athanassios A. Panagiotopoulos et al.
CANCER AND METASTASIS REVIEWS (2018)
Arginine and the metabolic regulation of nitric oxide synthesis in cancer
Rom Keshet et al.
DISEASE MODELS & MECHANISMS (2018)
Molecular Genetic Studies of Pancreatic Neuroendocrine Tumors: New Therapeutic Approaches
Mark Stevenson et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2018)
Quantitative metabolic flux analysis reveals an unconventional pathway of fatty acid synthesis in cancer cells deficient for the mitochondrial citrate transport protein
Lei Jiang et al.
METABOLIC ENGINEERING (2017)
Whole-genome landscape of pancreatic neuroendocrine tumours
Aldo Scarpa et al.
NATURE (2017)
mTORC1-dependent AMD1 regulation sustains polyamine metabolism in prostate cancer
Amaia Zabala-Letona et al.
NATURE (2017)
Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States
Arvind Dasari et al.
JAMA ONCOLOGY (2017)
Von Hippel-Lindau and Hereditary Pheochromocytoma/Paraganglioma Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in Childhood
Surya P. Rednam et al.
CLINICAL CANCER RESEARCH (2017)
Metabolomics and Metabolic Diseases: Where Do We Stand?
Christopher B. Newgard
CELL METABOLISM (2017)
Prognostic Impact of Novel Molecular Subtypes of Small Intestinal Neuroendocrine Tumor
Anna Karpathakis et al.
CLINICAL CANCER RESEARCH (2016)
Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study
James C. Yao et al.
LANCET (2016)
On determining the most appropriate test cut-off value: the case of tests with continuous results
Farrokh Habibzadeh et al.
BIOCHEMIA MEDICA (2016)
Altered metabolite levels in cancer: implications for tumour biology and cancer therapy
Lucas B. Sullivan et al.
NATURE REVIEWS CANCER (2016)
Biosynthesis, biological effects, and receptors of hydroxyeicosatetraenoic acids (HETEs) and oxoeicosatetraenoic acids (oxo-ETEs) derived from arachidonic acid
William S. Powell et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2015)
Identification of Hypoxanthine and Phosphoenolpyruvic Acid as Serum Markers of Chemoradiotherapy Response in Locally Advanced Rectal Cancer
Kun Kim et al.
CANCER RESEARCH AND TREATMENT (2015)
Heme oxygenase-1: emerging target of cancer therapy
Lee-Young Chau
JOURNAL OF BIOMEDICAL SCIENCE (2015)
Metabolomics provide new insights on lung cancer staging and discrimination from chronic obstructive pulmonary disease
Stanislaw Deja et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2014)
Metabolic fingerprint of Gestational Diabetes Mellitus
Danuta Dudzik et al.
JOURNAL OF PROTEOMICS (2014)
Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4)
Rajesh V. Thakker
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2014)
SMPDB 2.0: Big Improvements to the Small Molecule Pathway Database
Timothy Jewison et al.
NUCLEIC ACIDS RESEARCH (2014)
Data, information, knowledge and principle: back to metabolism in KEGG
Minoru Kanehisa et al.
NUCLEIC ACIDS RESEARCH (2014)
Method development and validation for rat serum fingerprinting with CE-MS: application to ventilator-induced-lung-injury study
Shama Naz et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2013)
Trials and tribulations of 'omics data analysis: assessing quality of SIMCA-based multivariate models using examples from pulmonary medicine
Asa M. Wheelock et al.
MOLECULAR BIOSYSTEMS (2013)
Metabonomic profiling: A novel approach in neuroendocrine neoplasias
James M. Kinross et al.
SURGERY (2013)
Metabolomic NMR Fingerprinting to Identify and Predict Survival of Patients with Metastatic Colorectal Cancer
Ivano Bertini et al.
CANCER RESEARCH (2012)
Pancreatic neuroendocrine tumors in patients with tuberous sclerosis complex
A. M. Larson et al.
CLINICAL GENETICS (2012)
Carnitine and Acylcarnitines
Stephanie E. Reuter et al.
CLINICAL PHARMACOKINETICS (2012)
Identification of a serum-detectable metabolomic fingerprint potentially correlated with the presence of micrometastatic disease in early breast cancer patients at varying risks of disease relapse by traditional prognostic methods
C. Oakman et al.
ANNALS OF ONCOLOGY (2011)
Human metabolic individuality in biomedical and pharmaceutical research
Karsten Suhre et al.
NATURE (2011)
Everolimus for Advanced Pancreatic Neuroendocrine Tumors.
James C. Yao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
DAXX/ATRX, MEN1, and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors
Yuchen Jiao et al.
SCIENCE (2011)
Regulation of cancer cell metabolism
Rob A. Cairns et al.
NATURE REVIEWS CANCER (2011)
Clinical and genetic aspects of neurofibromatosis 1
Kimberly Jett et al.
GENETICS IN MEDICINE (2010)
Update of the LIPID MAPS comprehensive classification system for lipids
Eoin Fahy et al.
JOURNAL OF LIPID RESEARCH (2009)
Polyamines and cancer: Old molecules, new understanding
EW Gerner et al.
NATURE REVIEWS CANCER (2004)
Localization of vascular endothelial growth factor and its receptors in digestive endocrine tumors: Correlation with microvessel density and clinicopathologic features
S La Rosa et al.
HUMAN PATHOLOGY (2003)
The intermediary metabolism of the prostate: A key to understanding the pathogenesis and progression of prostate malignancy
LC Costello et al.
ONCOLOGY (2000)
Share Paper
